Efficacy and safety of intravenous rituximab versus tacrolimus in frequently relapsing nephrotic syndrome
Latest Information Update: 22 Mar 2019
At a glance
- Drugs Rituximab (Primary) ; Tacrolimus
- Indications Nephrotic syndrome
- Focus Therapeutic Use
- Sponsors Intas Pharmaceuticals
Most Recent Events
- 22 Mar 2019 New trial record